Leading institutions and companies are leveraging artificial intelligence to revolutionize biotech R&D and healthcare. Google DeepMind unveiled AlphaGenome, a unified AI model predicting diverse genomic variant effects with superior performance. Lunit and Microsoft collaborate on cloud-based clinical AI. AI-assisted pathology enhances skin tumor evaluation accuracy. AI fuels drug repurposing for Rett syndrome, while integrated AI and bioprocessing aim to improve gene-edited therapy manufacturing. These advances signal a paradigm shift toward data-driven precision in life sciences.